Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemia

Overview of attention for article published in Blood, January 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 9 X users

bluesky: 5 Bluesky users

Readers on

mendeley: 41 Mendeley

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 60,333 followers.

RT @BloodJournal: Pegcetacoplan treatment increased Hb levels, reduced hemolysis, and increased FACIT-fatigue scale scores in patients with…

Pegcetacoplan treatment effectively increased hemoglobin levels and reduced hemolysis in patients with cold agglutinin disease and warm antibody autoimmune hemolytic anemia. by Roman E, Fattizzo B (...) Gertz MA et 6 al. in Blood https://t.co/EFRcCF6CG…

RT @BloodJournal: Pegcetacoplan treatment increased Hb levels, reduced hemolysis, and increased FACIT-fatigue scale scores in patients with…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 5 additional X posts.